• SENSEX 82,726.64
    539.83 (+0.66%)
  • BANKNIFTY 57,210.45
    454.45 (+0.80%)
  • Oberoi Realty
    1,751.00 1,440.05(%)
  • Canara Bank
    106.35 78.58(%)
  • SpiceJet
    40.84 79.90(%)
  • Lodha Developers
    1,330.55 1,036.00(%)
  • Havells India
    1,549.05 1,360.05(%)
  • ICICI Bank
    1,489.95 1,489.95(%)
  • One 97
    1,090.00 1,090.00(%)
  • Bombay Dyeing
    190.85 256.25(%)
  • Ola Electric
    43.95 157.53(%)
  • Dixon Technolog.
    16,671.15 19,149.80(%)
  • Anthem Bioscienc
    765.00 765.00(%)
  • Eternal Ltd
    303.60 311.60(%)
  • Paradeep Phosph.
    205.60 205.60(%)
  • Pidilite Inds.
    2,900.75 2,620.15(%)
  • Reliance Industr
    1,426.90 1,551.00(%)
  • I R F C
    136.90 208.95(%)
  • Monika Alcobev
    289.95 289.95(%)
  • St Bk of India
    825.00 889.00(%)
  • Waaree Energies
    3,199.00 3,740.75(%)
  • Jayaswal Neco
    43.10 55.34(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

BDH Industries Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 4720.0
  • ISIN : INE278D01018
331.80 -18 (-5.15%)
  • As on 23 Jul 2025 (EOD)

  • Today’s Low

    325.00

  • Today’s High

    353.00

  • Open

    353.00

  • Perv Close

    349.80

  • 52W Low

    241.00

  • 52W High

    417.85

Key Indicators

  • P/E(TTM)

    20.61

  • Mar.Cap (₹Cr.)

    191.12

  • Div & Yield %

    1.36

  • Book Value(₹)

    117.09

  • Debt-Equity Ratio

    -5.15

  • AGM Date

    23-Jul-2025

  • EPS

    16.10

  • P/E Ratio

    20.61

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    191.12

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    5.76

  • BV (₹)

    117.10

  • Sales( ₹ in Cr.)

    66.51

  • NP (in Cr.)

    9.27

  • NP Var(%)

    -6.0

  • Div%

    45.0

  • CPS (₹)

    17.70

  • EPS (₹)

    16.10

  • Traded Value (₹ in Lakhs)

    191.12

  • 52 Week High

    417.85

  • 52 Week Low

    241.00

  • Price BSE

    332.0

  • Price NSE

    1.00

  • Market Capital( in Cr.)

    191.12

  • P/C Ratio

    18.80

  • P/E Ratio

    20.60

  • Price Vs.BV

    16.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 66.51 85.83 74.46 69.39 57.45 59.48
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 66.51 85.83 74.46 69.39 57.45 59.48
Other Income 1.84 1.58 0.84 1.33 1.30 0.80
Stock Adjustments 1.00 -0.61 -1.89 0.55 1.17 -0.89
Total Income 69.35 86.80 73.41 71.27 59.92 59.39
EXPENDITURE :            
Raw Materials 42.39 59.66 47.80 49.53 38.35 35.26
Power and Fuel Cost 1.76 1.78 1.74 1.41 1.49 2.29
Employee Cost 7.44 7.43 6.96 6.62 6.26 7.50
Other Manufacturing Expenses 0.63 0.62 0.86 0.43 0.97 1.44
Selling and Administration Expenses 3.45 3.10 4.09 2.67 2.84 2.84
Miscellaneous Expenses 0.22 0.19 0.18 0.21 0.20 0.28
Employee Benefit Expenses 7.44 7.43 6.96 6.62 6.26 7.50
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 55.89 72.79 61.62 60.87 50.11 49.61
Operating Profit 13.44 14.01 11.80 10.42 9.81 9.77
Interest 0.07 0.18 0.16 0.23 0.28 0.69
Gross Profit 13.37 13.83 11.64 10.19 9.53 9.08
Depreciation 0.91 0.57 0.57 0.63 0.79 0.96
Profit Before Tax 12.46 13.26 11.07 9.56 8.74 8.12
Current Tax 2.54 2.94 2.87 2.33 2.45 2.27
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.65 0.44 -0.01 0.00 -0.06 -0.10
Reported Net Profit 9.27 9.87 8.20 7.22 6.36 5.94
Extraordinary Items 0.00 0.00 0.00 0.34 0.00 0.00
Adjusted Net Profit 9.27 9.87 8.20 6.88 6.36 5.94
Adjustment below Net Profit -0.08 -0.10 -0.01 0.04 -0.08 -0.45
P & L Balance brought forward 40.55 34.54 29.65 25.20 21.31 18.29
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 3.98 3.76 3.30 2.81 2.39 2.47
P & L Balance carried down 45.76 40.55 34.54 29.65 25.20 21.31
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 45.00 45.00 40.00 36.00 30.00 25.00
Dividend Per Share(Rs) 4.50 4.50 4.00 3.60 3.00 2.50
Earnings Per Share-Unit Curr 16.11 17.14 14.25 12.55 10.71 10.01
Earnings Per Share(Adj)-Unit Curr 16.11 17.14 14.25 12.55 10.71 10.01
Book Value 117.14 105.67 92.71 82.07 70.24 62.09
Book Value(Adj)-Unit Curr 117.14 105.67 92.71 82.07 70.24 62.09

Shareholding Pattern

  • Promoter Group

    49.70%

  • Public Share Holding

    50.30%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 464,380 464,380.00 464,380 464,380
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 464,380 8.07 464,380 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 2,396,760 41.63 2,396,660 18
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 2,396,760 41.63 2,396,660 18
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 16,024 0.28 16,024 1
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 16,024 0.28 16,024 1
2] Non Institution
Bodies Corporate 334,336 5.81 334,236 27
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 86,062 1.49 86,062 82
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 199,530 3.47 199,530 1
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 164,162 2.85 164,162 6
Individuals holding nominal share capital up to Rs. 1 lakh 1,507,542 26.18 1,426,342 4,775
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 588,504 10.22 588,504 103
Sub Total 2,880,136 50.03 2,798,836 4,994
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 5,757,300 100.00 5,675,900 5,014

Company Background

BDH Industries LtdPharmaceuticals - Indian - Formulations

  • BDH Industries Ltd
  • BSE Code : 4720.0
  • ISIN : INE278D01018

  • Incorporation Year

    1990

  • Registered Office

    Nair Baug
    Akurli Road Kandivli (E), Mumbai,
    Maharashtra-400101

  • Telephone

    91-22-28871370/28870834

  • FAX

    91-22-28868349

  • Chairman

    Jayashree Nair

  • Managing Director

    Jayashree Nair

  • Company Secretary

    Nikita Phatak

  • Auditor

    CLB & Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    TSR Consultants P Ltd
    C-101 1st Floor,
    247 Park Vikhroli W,Lal Bahadur Marg
    Mumbai - Mumbai - 400 083

BDH Industries Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
BDH Industries 331.80 68.35 66.51 20.61 18.12
Abbott India 34,745.50 6,684.73 6,409.15 52.20 44.95
Astrazeneca Phar 8,953.35 1,330.33 1,295.53 193.38 33.26
P & G Health Ltd 5,920.55 1,166.89 1,151.26 39.13 39.76
Glaxosmi. Pharma 3,130.55 3,866.05 3,723.49 57.71 58.72
Cipla 1,473.35 20,029.57 19,044.85 23.08 21.40
Amrutanjan Healt 692.60 437.58 421.23 39.40 20.84
Fermenta Biotec. 379.25 442.21 430.53 16.51 17.61
Guj. Themis Bio. 372.55 174.19 169.82 83.16 44.82
Bliss GVS Pharma 156.90 703.42 667.20 23.99 9.16
Ambalal Sarabhai 34.60 19.33 4.04 32.04 2.10